EOM Pharmaceuticals Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of EOM Pharmaceuticals Holdings generated cash of -$1,421,984, which is more than the previous year. Cash used in financing activities reached the amount of $1,087,000 last year. Net change in cash is therefore -$334,984.
Cash Flow
| 2012 | -12.38M | -9.82K | 31.95M |
|---|---|---|---|
| 2013 | -8.78M | -44.37K | 10.26M |
| 2014 | -9.93M | -28.57K | 5.54M |
| 2015 | -19.03M | -169.75K | 18.59M |
| 2016 | -19.86M | -4.01K | 8.70M |
| 2017 | -16.67M | 1.32K | 11.86M |
| 2020 | -1.23M | 0 | 1.5M |
| 2021 | -2.30M | 0 | 3.52M |
| 2022 | -2.62M | 0 | 1.75M |
| 2023 | -1.42M | 0 | 1.08M |
IMUC Cash Flow Statement (2012 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 613.24K | 1.48M | 262.97K | 6.62M | 11.43M | 22.60M | 23.22M | 27.64M | 26.21M | 6.65M |
Operating activities | ||||||||||
Net income | -1.61M | -2.64M | -5.14M | -1.45M | -14.31M | -22.08M | -12.79M | -9.37M | -8.80M | -14.5M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 0 | 0 | 0 | 47.76K | 75.11K | 36.19K | 47.65K | 50.40K | 45.82K |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 492.18K | 1.22M | 916.02K | 654.26K | 724.21K | 496.00K |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 492.18K | 1.22M | 916.02K | 654.26K | 724.21K | 496.00K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | -1.56M | 788.67K | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 146.43K | -221.54K | -2.20M | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 490.95K | 125.36K | 805.32K | -644.58K | 128.17K | -401.09K |
Cash generated by operating activities | -1.42M | -2.62M | -2.30M | -1.23M | -16.67M | -19.86M | -19.03M | -9.93M | -8.78M | -12.38M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 4 | 0 | 0 | 0 | 0 | -4.01K | -169.75K | -28.97K | -44.37K | -9.82K |
Acquisitions Net | 0 | 0 | 0 | 0 | 1.32K | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | 1.32K | -4.01K | -169.75K | -28.57K | -44.37K | -9.82K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 1.5M | 11.86M | 7.03M | 14.59M | 4.49M | 4.90M | 28.73M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -2.50M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 1.08M | 1.75M | 3.52M | 1.5M | 11.86M | 8.70M | 18.59M | 5.54M | 10.26M | 31.95M |
Net Change In Cash | -334.98K | -873.32K | 1.22M | -6.36M | -4.80M | -11.16M | -617.81K | -4.42M | 1.42M | 19.56M |
Cash at end of period | 278.26K | 613.24K | 1.48M | 262.97K | 6.62M | 11.43M | 22.60M | 23.22M | 27.64M | 26.21M |
| Data source | Data source | Data source | Data source | Data source | Data source |